Physician profile
Peter K Henke
NPI 1881794618
$8,285.12
in general payments reported to CMS, 2019-2025
12 companies · $534 in 2025
The $534 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,592 · 2020: $142 · 2021: $3,741 · 2022: $283 · 2023: $520 · 2024: $473 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $3,200.00 | 2021 | |
| Admedus Corporation | $2,375.00 | 2019 | |
| Medtronic, INC. | $1,258.09 | 2021-2025 | Endurant Iis, Valiant Captivia |
| W. L. Gore & Associates, INC. | $564.83 | 2020-2024 | Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Heartflow, INC. | $292.80 | 2021-2022 | |
| Medtronic Vascular, INC. | $217.20 | 2019 | |
| Silk Road Medical, INC. | $132.89 | 2022 | |
| Endologix LLC | $118.16 | 2025 | |
| Bard Peripheral Vascular, INC. | $64.73 | 2023-2024 | Lutonix Drug Coated Balloon |
| Surmodics, INC. | $33.55 | 2024 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy System |
| Ethicon US, LLC | $15.11 | 2025 | Surgicel Nu-Knit |
| Janssen Pharmaceuticals, INC | $12.76 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Henke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.